New research from the Safe Motherhood Program demonstrates that the NASG significantly reduces blood loss in women who experience post-abortion hemorrhage and results in a clinically important 52% lower odds of mortality. This study was conducted with partners at Los Angeles Medical C

UCSF’s Safe Motherhood Program and colleagues have tested a novel approach to manage postpartum hemorrhage: ‘secondary prevention/early treatment’  using misoprostol to treat only women with above average bleeding.   This study demonstrates secondary prevention/early treat